Evan Seigerman analyst BMO

Currently out of the existing stock ratings of Evan Seigerman, 295 are a BUY (66.44%), 124 are a HOLD (27.93%), 25 are a SELL (5.63%).

Evan Seigerman

Work Performance Price Targets & Ratings Chart

Analyst Evan Seigerman, currently employed at BMO, carries an average stock price target met ratio of 73.2% that have a potential upside of 33.86% achieved within 284 days.

Evan Seigerman’s has documented 886 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on AMGN, Amgen.

Wall Street Analyst Evan Seigerman

Analyst best performing recommendations are on PTGX (PROTAGONIST THERAPEUTICS).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 10/8/2025. The price target of $72 was fulfilled within 2 days with a profit of $6.7 (10.26%) receiving and performance score of 51.3.

Average potential price target upside

ACRX AcelRx Pharmaceuticals AIMT Aimmune Therapeutics AMGN Amgen BIIB Biogen BMY Bristol-Myers Squibb Company GILD Gilead Sciences GRTX Galera Therapeutics INCY yte LLY Eli Lilly and Company MRTX Mirati Ther NBIX Neurocrine Biosciences PFE Pfizer REGN Regeneron Pharmaceuticals STSA Satsuma Pharmaceuticals VRTX Vertex Pharmaceuticals NUVB Nuvation Bio REPL Replimune Group CADL Candel Therapeutics MGNX MacroGenics MRK Merck mpany GLPG Galapagos NV ADR IKNA Ikena Oncology MORF Morphic GPCR Structure Therapeutics American Depositary Shares IRON Disc Medicine ALDR Alder BioPharmaceuticals NVO Novo Nordisk A/S ABBV AbbVie ACAD ACADIA Pharmaceuticals AI C3 Ai BNTX BioNTech SE PTGX Protagonist Therapeutics SDGR Schrodinger SRRK Scholar Rock Holding Corp ST Sensata Technologies Holding NV TERN Terns Pharmaceuticals NGNE Neurogene

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Sep-2023

2 years 9 months 5 days ago
(07-Dec-2023)

0/2 (0%)

$68.1 (94.71%)

Buy Since 05-Nov-2018

$4

$2.87 (253.98%)

$9

4 years 9 months 11 days ago
(01-Dec-2021)

2/2 (100%)

$-8.43 (-67.82%)

670

Buy Since 16-Aug-2018

$4

$2.87 (253.98%)

$7

5 years 5 months 27 days ago
(16-Mar-2021)

3/3 (100%)

$-33.2 (-89.25%)

1106

Sell Since 13-Aug-2020

$16.6

$15.47 (1369.03%)

$16.8

5 years 10 months 6 days ago
(06-Nov-2020)

4/4 (100%)

$-12.4 (-42.76%)

335

Buy Since 09-May-2019

$120

$118.87 (10519.47%)

7 years 4 months 3 days ago
(09-May-2019)

0/1 (0%)

$56.4 (88.68%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Evan Seigerman most bullish on?

Potential upside of $72.65 has been obtained for AMGN (AMGEN)

Which stock is Evan Seigerman most reserved on?

Potential downside of $2.28 has been obtained for PFE (PFIZER)

What Year was the first public recommendation made by Evan Seigerman?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?